Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care

American Journal of Hypertension

Volumn 26, Issue 5, 2013, Pages 700-707

  Ravera, Maura ^a   Noberasco, Giuseppe ^b   Signori, Alessio ^c   Re, Michela ^c   Filippi, Alessandro ^b   Cannavò, Rossella ^a   Weiss, Ursula ^a   Cricelli, Claudio ^b   Deferrari, Giacomo ^a   Paoletti, Ernesto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Italian College of General Practitioners SIMG   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

blood pressure; chronic kidney disease; hypertension; left ventricular hypertrophy; primary care; renal outcome

Indexed keywords

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY;

AGED; COHORT STUDIES; COMORBIDITY; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PRIMARY HEALTH CARE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES;

EID: 84876512905     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hps100     Document Type: Article

References (32)

1. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 2005;165:923-928. (Pubitemid 40563240)
2. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010;303: 2043-2050.
3. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164: 659-663. (Pubitemid 38392981)
4. Hu B, Gadegbeku C, Lipkowitz MS, Rostand S, Lewis J, Wright JT, Appel LJ, Greene T, Gassman J, Astor BC; African-American Study of Kidney Disease and Hypertension Group. Kidney function can improve in patients with hypertensive CKD. J Am Soc Nephrol 2012;23:706-713.
5. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-2081.
6. Elsayed EF, Tighiouart H, Griffith J, Kurth T, Levey AS, Salem D, Sarnak MJ, Weiner DE. Cardiovascular disease and subsequent kidney disease. Arch Intern Med 2007;167:1130-1136. (Pubitemid 46919815)
7. Tsioufis C, Kokkinos P, Mac Manus C, Thomopoulos C, Faselis C, Doumas M, Stefanadis C, Papademetriou V. Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk. J Hypertens 2010;28:2299-2308.
8. Paoletti E, Bellino D, Gallina AM, Amidone M, Cassottana P, Cannella G. Is left ventricular hypertrophy a powerful predictor of progression to dialysis in chronic kidney disease Nephrol Dial Transplant 2011;26: 670-677.
9. Chen SC, Su HM, Hung CC, Chang JM, Liu WC, Tsai JC, Lin MY, Hwang SJ, Chen HC. Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease. Clin J Am Soc Nephrol 2011;6:2750-2758.
10. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP.Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566. (Pubitemid 20176696)
11. Deferrari G. General practitioners and nephrologists for outpatient assistance. http://www.controlled-trials.com/isrctn/ISRCTN09810203.
12. Ravera M, Noberasco G, Weiss U, Re M, Gallina AM, Filippi A, Cannavò R, Ravera G, Cricelli C, Deferrari G. CKD awareness and blood pressure control in the primary care hypertensive population. Am J Kidney Dis 2011;57:71-77.
13. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JD, Eggers P, Van Lente F, Greene T, Coresh J. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150: 604-612.
14. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(Suppl 1):S1-S266.
15. Verdecchia P, Staessen JA, Angeli F, de Simone G, Achilli A, Ganau A, Mureddu G, Pede S, Maggioni AP, Lucci D, Reboldi G, on behalf of the Cardio-Sis Investigators. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomized trial. Lancet 2009;374:525-533.
16. Mancia G, de Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187. (Pubitemid 46924065)
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
18. Schafer JL. Analysis of Incomplete Multivariate Data. Boca Raton, FL: Chapman & Hall/CRC, 1997.
19. Allison PD. Missing Data. Thousand Oaks, CA: Sage, 2001.
20. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;338:b2393
21. Marchais SJ, Guerin AP, Pannier BM, Levy BI, Safar ME, London GM. Wave reflections and cardiac hypertrophy in chronic uremia: influence of body size. Hypertension 1993;22:876-883. (Pubitemid 23358096)
22. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney. Cause and logic of therapy. Hypertension 2005;46:200-204. (Pubitemid 40946514)
23. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in abroad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009;53:582-588.
24. Salvetti M, Muiesan ML, Paini A, Monteduro C, Bonzi B, Galbassini G, Belotti E, Movilli E, Cancarini G, Agabiti-Rosei E. Myocardial ultrasound tissue characterization in patients with chronic renal failure. J Am Soc Nephrol 2007;18:1953-1958. (Pubitemid 46870333)
25. Pontremoli R, Ravera M, Bezante GP, Viazzi F, Nicolella C, Berruti V, Leoncini G,Del Sette M, Brunelli C, Tomolillo C, Deferrari G. Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. J Hypertens 1999;17:993-1000. (Pubitemid 29322188)
26. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS. Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol 2004;15:1029-1037. (Pubitemid 38375322)
27. Devereux RB. Is the electrocardiogram still useful for detection of left ventricular hypertrophy Circulation 1990;81:1144.
28. Schillaci G, Battista F, Pucci G. A review of the role of electrocardiography in the diagnosis of leftr ventricular hypertrophy in hypertension. J Electrocardiol 2012; http://dx.doi.org/10.1016/jelectrocard. 2012.08051
29. Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas LG, Neaton JD. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor interventional trial. J Am Soc Nephrol 2006;17:1444-1452. (Pubitemid 43673426)
30. van der Velde M, Halbesma N, de Charro FT, Bakker SJ, de Zeeuw D,de Jong PE, Gansevoort RT. Screening for albuminuria identifies individuals at increased renal risk. J Am Soc Nephrol 2009;20:852-862.
31. Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 2009;20:1069-1077.
32. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J; Chronic Kidney Disease Prognosis Consortium. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011;80:93-104.